Institut du Cancer de Montpellier - Val d'Aurelle: Rectal Neoplasms trials
The registry lists 12 Rectal Neoplasms studies with Institut du Cancer de Montpellier - Val d'Aurelle as lead sponsor. 5 are open to participants now and 0 have results posted.
Phase 2 3Phase 3 2No phase 8(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Multidimensional Study Designed to Develop a Methodological Framework Based on MRI Data to Predict Pathological Complete Response (pCR) in Patients With Locally Advanced Rectal Cancer After Neoadjuvant TreatmentNot yet recruitingNCT07404228
- Contribution of Preserving the Superior Left Colic Artery to the Vascularization of the Descending Colon Prior to Colorectal Anastomosis During Left-Sided or Rectal Resections for Colorectal or Ovarian Cancer. (Revascularisation Colique)RecruitingNCT07098182Not applicable
- Study Evaluating the Tailored Management of Locally-advanced Rectal CarcinomaRecruitingNCT04749108Phase 2/3
- Determination of Microbiological Factors Associated With Poor Response to Neoadjuvant Treatment in Rectal CancersRecruitingNCT04103567Not applicable
- Development of a Clinical and Biological Database in Rectum CancerRecruitingNCT04006951Not applicable
- Liquid Biopsies and IMAging for Improved Cancer CareActive, not recruitingNCT04224779Not applicable
- Robotic Low Rectum Anterior ResectionCompletedNCT04015804Not applicable
- Rectal Surgery Evaluation Trial (RESET)CompletedNCT03574493
- Multicenter Phase 2 Trial: a Tailored Strategy for Locally Advanced Rectal CarcinomaCompletedNCT01333709Phase 2
- Sphincter-preserving Surgery After Preoperative Treatment of Ultra-low Rectal CarcinomaCompletedNCT00979680Phase 3
- Biological Factors in Predicting Response to Treatment in Patients With Esophageal Cancer or Rectal CancerCompletedNCT00628368Not applicable
- Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal CancerCompletedNCT00556413Phase 2